Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis
Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis have?
Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis has 32 citations in the OpenAlex counts ScholarIQ stores.
When was Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis published?
Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis has 2023 year in the ScholarIQ index.
What is the open-access status of Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis?
Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis has gold oa status in the ScholarIQ index.
What is the DOI of Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis?
The DOI for Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis is on the source record.
What is the PMID of Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis?
The PMID for Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis is on the source record.
What is the OpenAlex record for Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis?
The OpenAlex for Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis is on the source record.